Evaluating the efficacy of stent retriever and catheter aspiration combination in refractory cerebral venous sinus Thrombosis: A comprehensive Meta-Analysis

Nenhuma Miniatura disponível
Citações na Scopus
1
Tipo de produção
article
Data de publicação
2024
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER SCI LTD
Autores
BATISTA, Savio
SANCHES, Joao Pedro Bittar
ANDREA, Filipi Fim
SOUSA, Marcelo Porto
OLIVEIRA, Leonardo de Barros
FERREIRA, Marcio Yuri
FILHO, Cesar Augusto Ferreira Alves
BRAGA, Fausto de Oliveira
MACHADO, Elias Antonio Tanus
Citação
JOURNAL OF CLINICAL NEUROSCIENCE, v.120, p.154-162, 2024
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background: Cerebral Venous Sinus Thrombosis (CVST) is a rare but potentially life-threatening condition, often associated with specific risk factors. The primary treatment for CVST is anticoagulation, but some cases progress to Refractory CVST (rCVST), requiring endovascular treatment. A combination of stent retriever and catheter aspiration is emerging as a promising technique to enhance treatment effectiveness. We conducted a systematic review and meta-analysis to assess the safety and efficacy of this approach, aiming to improve recanalization success and neurological outcomes while reducing complications in rCVST patients. Methods: A search following PRISMA guidelines was conducted across Pubmed, Embase, Web of Science, and Cochrane databases to identify studies on the use of stent retrievers and catheter aspiration for rCVST. Pooled analysis with 95 % confidence intervals was used to assess the effects. Heterogeneity was evaluated using I2 statistics and a random-effects model was used. Complete recanalization. good clinical outcomes (mRS <= 2), hemorrhagic, neurological, ischemic, and total complications, poor clinical outcomes (mRS > 2), and mortality were assessed. Results: A meta-analysis of five retrospective studies involving 55 patients examined outcomes in CVST. The median mean age was 40 years. Complete recanalization rate: 36 % (95 % CI: 9 % to 62 %, I-2 = 90 %). Good clinical outcomes: 72 % (95 % CI: 50 % to 94 %, I-2 = 76 %). Hemorrhagic complications: 2 % (95 % CI: 0 % to 8 %, I-2 = 15 %). Ischemic complications: 0 % (95 % CI: 0 % to 6 %, I-2 = 0 %). Neurological complications: 7 % (95 % CI: 0 % to 14 %, I-2 = 0 %). Poor clinical outcomes: 26 % (95 % CI: 6 % to 46 %, I-2 = 70 %). Total complications: 6 % (95 % CI: 0 % to 15 %, I-2 = 10 %). Mortality rate: 5 % (95 % CI: 0 % to 13 %, I-2 = 19 %). Conclusion: This systematic review and meta-analysis scrutinized the efficacy of combining Stent Retriever and Catheter Aspiration for rCVST. Findings highlighted varied outcomes, including recanalization rates, complications, and mortality. The dichotomy between good and poor outcomes underscores the necessity for personalized therapeutic decisions. While offering a comprehensive overview, the study emphasizes literature heterogeneity, suggesting a need for more rigorous and standardized research to optimize therapeutic strategies in clinical practice.
Palavras-chave
Cerebral venous sinus thrombosis, Stent retriever, Catheter aspiration, Refractory cerebral venous sinus thrombosis
Referências
  1. Agrawal K, 2016, HEADACHE, V56, P1380, DOI 10.1111/head.12873
  2. Arauz A, 2016, J NEUROL NEUROSUR PS, V87, P247, DOI 10.1136/jnnp-2014-310068
  3. Canhao P, 2003, CEREBROVASC DIS, V15, P159, DOI 10.1159/000068833
  4. Capecchi M, 2018, J THROMB HAEMOST, V16, P1918, DOI 10.1111/jth.14210
  5. Coutinho J, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD002005.pub2, 10.1002/14651858.CD002005]
  6. Coutinho JM, 2014, STROKE, V45, P1338, DOI 10.1161/STROKEAHA.113.004666
  7. Dandapat S, 2020, INTERV NEURORADIOL, V26, P26, DOI 10.1177/1591019919865957
  8. Dashti SR, 2013, J NEUROINTERV SURG, V5, P49, DOI 10.1136/neurintsurg-2011-010112
  9. de Bruijn SFTM, 1999, STROKE, V30, P484, DOI 10.1161/01.STR.30.3.484
  10. Deschiens MA, 1996, STROKE, V27, P1724, DOI 10.1161/01.STR.27.10.1724
  11. Ferro JM, 2017, EUR J NEUROL, V24, P1203, DOI 10.1111/ene.13381
  12. Ferro JM, 2004, STROKE, V35, P664, DOI 10.1161/01.STR.0000117571.76197.26
  13. Garge SS, 2014, NEUROL INDIA, V62, P521, DOI 10.4103/0028-3886.144448
  14. Gunes HN, 2016, J INT MED RES, V44, P1454, DOI 10.1177/0300060516664807
  15. Guo XB, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-78570-1
  16. Guo XB, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01185
  17. Haghighi AB, 2014, CLIN APPL THROMB-HEM, V20, P507, DOI 10.1177/1076029612470968
  18. Hirsch JA, 2013, J NEUROINTERV SURG, V5, P621, DOI [10.1136/neurintsurg-2012-010332, 10.1136/neurintsurg-2012-010325, 10.1136/neurintsurg-2012-010331]
  19. Ilyas A, 2017, J NEUROINTERV SURG, V9, P1086, DOI 10.1136/neurintsurg-2016-012938
  20. Janghorbani M, 2008, ACTA NEUROL SCAND, V117, P117, DOI 10.1111/j.1600-0404.2007.00915.x
  21. Jankowitz BT, 2013, J NEUROINTERV SURG, V5, P534, DOI 10.1136/neurintsurg-2012-010476
  22. Khealani BA, 2008, STROKE, V39, P2707, DOI 10.1161/STROKEAHA.107.512814
  23. Komro J, 2020, CUREUS J MED SCIENCE, V12, DOI 10.7759/cureus.7654
  24. Konakondla S, 2017, AGING DIS, V8, P136, DOI 10.14336/AD.2016.0915
  25. Lanska DJ, 1997, OBSTET GYNECOL, V89, P413
  26. Lee H, 2021, FRONT NEUROL, V12, DOI 10.3389/fneur.2021.663058
  27. Liao CH, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-61884-5
  28. Luo YX, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00002
  29. Moher D., 2009, PLOS MED, V6, DOI [DOI 10.1371/JOURNAL.PMED.1000097, 10.1371/journal.pmed.1000097]
  30. Mokin M, 2015, INTERV NEURORADIOL, V21, P520, DOI 10.1177/1591019915583015
  31. Ng PP, 2019, J NEUROINTERV SURG, V11, P127, DOI 10.1136/neurintsurg-2018-013873
  32. Nyberg EM, 2017, J STROKE CEREBROVASC, V26, P2240, DOI 10.1016/j.jstrokecerebrovasdis.2017.05.006
  33. Peng T, 2022, FRONT NEUROL, V12, DOI 10.3389/fneur.2021.783380
  34. Qiu ZM, 2015, J THROMB THROMBOLYS, V40, P353, DOI 10.1007/s11239-015-1205-7
  35. Shui SF, 2014, NEUROL INDIA, V62, P371, DOI 10.4103/0028-3886.141241
  36. Siddiqui FM, 2015, STROKE, V46, P1263, DOI 10.1161/STROKEAHA.114.007465
  37. Siddiqui FM, 2014, INTERV NEURORADIOL, V20, P336, DOI 10.15274/NRJ-2014-10032
  38. Slim K, 2003, ANZ J SURG, V73, P712, DOI 10.1046/j.1445-2197.2003.02748.x
  39. Stam J, 2005, NEW ENGL J MED, V352, P1791, DOI 10.1056/NEJMra042354
  40. Styczen H, 2019, WORLD NEUROSURG, V127, pE1097, DOI 10.1016/j.wneu.2019.04.049
  41. Tang SZ, 2023, NEUROSURG REV, V46, DOI 10.1007/s10143-023-02012-5
  42. Zheng SF, 2022, WORLD NEUROSURG, V167, pE990, DOI [10.1016/J.WnEU.2022.08.123, 10.1016/j.wneu.2022.08.123]